Skip to main content

IND Communities To Participate In $507M Opioid Settlement

IND Communities To Participate In $507M Opioid Settlement

IND Communities To Participate In $507M Opioid Settlement

Introduction

Indiana's Attorney General informed that all the cities, towns and counties in Indiana are now participating in the $507 million opioid settlement with major pharmaceutical distributors and manufacturers.

A total of 46 states and many local governments alleged the four companies, including pharmaceutical distributors Cardinal Health, McKesson and AmerisourceBergen, along with manufacturer and marketer Johnson & Johnson, to acquire the settlement. The settlement is part of a $26 billion nationwide agreement where the opioid makers and distributors will pay for the opioid crisis throughout the nation.

The AG said that the settlement amount is not sufficient to compensate the families who have lost their loved ones. But it will help to prevent a future similar crisis by providing decent funds to implement prevention strategies. The important programs that would be funded by the settlement include drug task forces, regional treatment hubs, early intervention, crisis support and local law enforcement efforts.

As per the agreement, 70% of the funds would be used for opioid abatement efforts in local communities. The state and local leaders would decide about spending the amount in equal halves. The remaining 305 would also be divided equally between state and local communities so the leaders can decide the best way to spend the money.

The AG informed that the disbursement plan for the opioid settlement is executed to make sure that the local and individual communities receive maximum funding and could decide the usage of the funds.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!